Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONVERT-H: Conivaptan in ADHF with Hyponatremia
NCT00843986Phase 3Terminated
- Sponsor
- Cumberland Pharmaceuticals
- Start
- Apr 2009
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of conivaptan in hyponatremia, sponsored by Cumberland Pharmaceuticals. Started Apr 2009; status: terminated.
02
Drugs
conivaptan
03
Conditions
hyponatremia
Beyond the preview
Go deeper on NCT00843986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00843986.